Sorry, you need to enable JavaScript to visit this website.
PGS Sanford, N.C.

PGS Sanford, NC

The 230-acre site in Sanford, North Carolina, just south of the famed Research Triangle, is home to one of the largest U.S. biotechnology hubs. The site has flexible, multi-product manufacturing capabilities and facilities focused on vaccines intermediates and drug substance, and gene therapy drug substance and drug product.

The vaccine manufacturing capabilities center on large-scale microbial fermentation, purification, conjugation and cell banking. Gene therapy capabilities include cell culture, purification, drug product formulation and filling, and inspect, label and primary packaging.

Sanford has been certified as a Carolina STAR site since 2007; the equivalent of an OSHA VPP certification recognizing safety excellence.

In 2017, Pfizer invested $100 million in a state-of-the-art gene therapy facility where clinical trial material drug substances and drug products are produced for Duchenne Muscular Dystrophy, hemophilia B and hemophilia A gene therapy candidates. In 2019, Pfizer announced an additional investment of $500 million for the construction of its facility for the production of gene therapies.

Turning the Promise of Gene Therapy into a Reality
Read More

PGS St. Louis, Mo.
PGS St. Louis, MO
In St. Louis, Meridian Medical Technologies produces innovative emergency care products that serve unique needs during severe medical crises.
PGS Rocky Mount, N.C.
PGS Rocky Mount, NC
The Rocky Mount site is one of the largest sterile injectable facilities in the world, with more than 1.4 million square feet of manufacturing space on 250 acres in Eastern North Carolina.
St. Louis, MO
A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises
PGS Rochester, Mich.
PGS Rochester, MI
In Rochester, King Pharmaceuticals, a subsidiary of Pfizer, manufactures and packages penicillin, the only approved treatment for late stage syphilis.
Sandwich, UK
Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups
PGS Pearl River, N.Y. 454 x 605
PGS Pearl River, NY
With more than 100 years of rich history in innovation and manufacturing excellence, 19 products- including various vaccines, antibiotics, and oncology medicines, have been discovered, developed, and approved at the Pearl River, New York site.
Pearl River
Pearl River, New York
The primary location for our company’s global Vaccine Research and Development work
La Jolla, California
Powerfully reinforcing the company's presence in the global biotechnology industry
Groton, Connecticut
Where nearly every one of our products are, in part, developed
Cambridge, Massachusetts
Global headquarters for our Center for Therapeutic Innovation (CTI), which has established locations in New York City, San Diego, and San Francisco
PGS Middleton, Wis. 454x605
PGS Middleton, WI
Since 1982, the Middleton site has focused on the manufacture of biologics. The 83,000-square-foot facility isolates bovine thrombin, a naturally occurring enzyme which plays a critical role in rapid clotting (hemostasis) of blood.
PGS McPherson, Kan. 454 x 605
PGS McPherson, KS
The McPherson site specializes in manufacturing sterile injectable medicines used daily in hospitals around the world.